Ambea AB (publ) (AMBEA.ST) Debt-to-Equity Ratio
As of May 23, 2026
TL;DR — AMBEA.ST debt-to-equity is 2.43
Ambea AB (publ) (AMBEA.ST) currently carries a debt-to-equity ratio of 2.43 (high). Interest coverage is N/A and the current ratio is 0.41. Significantly debt-heavy. Often seen in financials (which are not directly comparable) and in companies executing aggressive buybacks. Cash-flow durability is the key question.
Current leverage profile
Debt / Equity
2.43
Total debt / shareholder equity
Interest coverage
N/A
EBIT / interest expense
Current ratio
0.41
Short-term liquidity
D/E in isolation is a starting point, not a verdict. To get a credible read on solvency you also want to see interest coverage above 3x (so EBIT comfortably pays interest) and a current ratio above 1.2 (so short-term assets cover short-term obligations). When those two are healthy, even a higher D/E is usually manageable.
5-Year debt-to-equity trend
The direction of travel matters as much as the absolute level. A D/E that has been rising over the past five years tells you the management team is leaning more on debt — either to fund growth (good if returns on capital exceed cost of debt) or because cash flow can't keep up (bad).
Series illustrated from current D/E. Full 5-year quarterly history ships in the upcoming balance-sheet ingest.
Industry comparison
The Healthcare sector median D/E is roughly 0.55. AMBEA.ST's reading of 2.43 is currently ~342% above the sector median, meaning AMBEA.ST is materially more reliant on debt than its peers. Stress-test the dividend, the next major maturity, and the interest coverage before owning it..
Compare AMBEA.ST against every Healthcare peer in the full sector list.
Interpreting AMBEA.ST's debt-to-equity
What "High" means here: Significantly debt-heavy. Often seen in financials (which are not directly comparable) and in companies executing aggressive buybacks. Cash-flow durability is the key question.
Sector context matters: a D/E of 1.5 in financials or utilities is normal. The same number in software or pharma is a yellow flag. Always anchor your read against the sector median above before forming a view.
Watch the direction: a slowly rising D/E is fine if return on invested capital (see the fundamentals page) is comfortably above the cost of debt. A rapidly rising D/E paired with deteriorating ROIC is the classic distressed-equity pattern.
Stress test: ask yourself what AMBEA.ST looks like if revenue drops 20% for two years. With its current interest coverage of N/A, can the company keep paying interest? The Altman Z-Score on the fundamentals page is a quick formal version of this question.
Related AMBEA.ST analyses
Frequently asked about AMBEA.ST debt-to-equity
What is AMBEA.ST's debt-to-equity ratio?↓
AMBEA.ST's current debt-to-equity ratio is 2.43 as of May 23, 2026. That puts it in the "High" category. Significantly debt-heavy. Often seen in financials (which are not directly comparable) and in companies executing aggressive buybacks. Cash-flow durability is the key question.
How is debt-to-equity calculated?↓
Debt-to-equity = total debt / shareholders' equity. Total debt usually includes both short-term and long-term interest-bearing borrowings (sometimes called total liabilities in older definitions). We use the FMP "debtEquityRatioTTM" field, which is total debt over equity on a trailing twelve-month basis.
Is AMBEA.ST's D/E ratio safe?↓
"Safe" depends on the business model. A 2.43 D/E is high. The more important question is cash coverage: with an interest-coverage ratio of N/A and a current ratio of 0.41, AMBEA.ST can service its debt obligations at the current operating level.
How does AMBEA.ST compare to the Healthcare average?↓
The Healthcare sector median D/E is roughly 0.55. AMBEA.ST's 2.43 is materially more levered than peers (about 342% above the median).
When is high debt-to-equity dangerous?↓
High D/E is dangerous when (1) cash flow coverage is weak (interest coverage below 3x), (2) earnings are cyclical or capital-intensive, (3) refinancing exposure is concentrated in the next 12-24 months, (4) the company is paying out a large dividend or running buybacks while issuing more debt. Conversely, high D/E can be perfectly fine for stable-cash-flow utilities, REITs, and regulated financials — context matters.